<?xml version="1.0" encoding="UTF-8"?>
<rss version="2.0"
        	xmlns:content="http://purl.org/rss/1.0/modules/content/"
	xmlns:wfw="http://wellformedweb.org/CommentAPI/"
	xmlns:dc="http://purl.org/dc/elements/1.1/"
	xmlns:atom="http://www.w3.org/2005/Atom"
	xmlns:sy="http://purl.org/rss/1.0/modules/syndication/"
	xmlns:slash="http://purl.org/rss/1.0/modules/slash/"
    xmlns:s="https://www.cbsnews.com/"

    xmlns:media="http://search.yahoo.com/mrss/"
>
    <channel>
        
        
               

            <title>Sponsored Content - CBSNews.com</title>
    <link>https://www.cbsnews.com/</link>
    <description>Sponsored Content From CBSNews.com</description>
    <pubDate>Wed, 08 Apr 2026 22:03:17 -0400</pubDate>
    <ttl>5</ttl>
            
                    <item>
                
    <title>How to prepare for this year&#039;s flu season ahead of its peak</title>
    <link>https://www.cbsnews.com/video/how-to-prepare-for-this-years-flu-season-ahead-of-its-peak/</link>
    <description>(Sponsored By Walgreens) Doctors are preparing for a wave of influenza activity after a record-setting flu season. Walgreens Chief Pharmacy Officer Rick Gates joins &quot;CBS Mornings&quot; to answer questions about this year&#039;s flu season and explain why he recommends getting the flu shot ahead of peak flu season.</description>

            <pubDate>Thu, 30 Oct 2025 10:19:00 -0400</pubDate>
    
                    

	    	        <image>https://assets2.cbsnewsstatic.com/hub/i/r/2025/10/30/4b37a256-dd52-461c-8bb5-d68151a51bb0/thumbnail/60x60/8b30c58b1e250cdc08caf8ef7d25f234/cbsm-cr470c-monday-friday-clean-8-12-21-am-2025-10-30-ssxqwyvj.jpg</image>
	        
    
    <guid isPermaLink="false">a737ea52-cd75-4768-897c-3f842f633558</guid>
        </item>
            <item>
                
    <title>Tiny eyelash mites can cause a common eye disease. How can we protect our eyes?</title>
    <link>https://www.cbsnews.com/video/tiny-eyelash-mites-can-cause-a-common-eye-disease-how-can-we-protect-our-eyes/</link>
    <description>Demodex blepharitis impacts an estimated 25 million people in the U.S., yet many have never heard of it. In partnership with Tarsus Pharmaceuticals, &quot;CBS Mornings&quot; explores the connection between eye health and overall well-being, and looks at their FDA-approved drug XDEMVY® used to help treat the disease. Sponsored by XDEMVY. Rx only. Visit &lt;a href=&quot;https://Xdemvy.com&quot; target=&quot;_blank&quot;&gt;XDEMVY.com&lt;/a&gt; and ask your doctor if XDEMVY is right for you. Yuna Rapoport, M.D. is a paid spokesperson for Tarsus Pharmaceuticals, Inc. The most common side effect in clinical trials was stinging and burning in 10% of patients. Other side effects in less than 2% of patients were chalazion/hordeolum and punctate keratitis. Please see additional important safety information &lt;a href=&quot;https://bit.ly/XDEMVY-ISI&quot; target=&quot;_blank&quot;&gt;here&lt;/a&gt; and full prescribing information &lt;a href=&quot;https://bit.ly/XDEMVY-PI&quot; target=&quot;_blank&quot;&gt;here&lt;/a&gt; and available at &lt;a href=&quot;https://Xdemvy.com&quot; target=&quot;_blank&quot;&gt;XDEMVY.com&lt;/a&gt;. XDEMVY (lotilaner ophthalmic solution) 0.25% is indicated for the treatment of Demodex blepharitis.</description>

            <pubDate>Wed, 02 Jul 2025 09:34:00 -0400</pubDate>
    
                    

	    	        <image>https://assets1.cbsnewsstatic.com/hub/i/r/2025/06/25/cbfe56c1-5c45-4162-9bd2-c26a57128865/thumbnail/60x60/2593407416c61967e7336be2e86e92c5/screenshot-2025-06-25-at-4-29-08-pm.png</image>
	        
    
    <guid isPermaLink="false">f6ad6a3a-ef73-4190-ad1d-f3977aa6438e</guid>
        </item>
        </channel>
</rss>